Favorite Annette F 4

What Happened Annette F. Favorite, Senior VP & Chief HR Officer of West Pharmaceutical Services (WST), received 441.957 shares from vested performance stock units (PSUs) on Feb 17–18, 2026. The filing shows tax-withholding share dispositions of 150.443 shares on Feb 17 at $243.19 (proceeds/value $36,586) and 35.757 shares on Feb 18 at $248.26 (value $8,877). The report also includes exercise/conversion (derivative) entries of 135.491 shares on Feb 18 associated with the settlement/conversion of equity awards.

Key Details

• Transaction dates: Feb 17, 2026 (award and withholding) and Feb 18, 2026 (conversion/exercise and withholding). Filing date: Feb 19, 2026.
• Award: 441.957 shares (code A) from PSUs that vested at the end of the 2023–2025 performance period (footnote F1).
• Tax withholding: 150.443 shares @ $243.19 = $36,586 (Feb 17) and 35.757 shares @ $248.26 = $8,877 (Feb 18); total withheld ≈ 186.200 shares, $45,463.
• Derivative/Conversion: Entries show conversion/exercise (code M) for 135.491 shares on Feb 18 (filing lists both acquired and related derivative disposal entries).
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnotes: F1 = PSUs vested and payable on the transaction date. F2 notes RSUs convert one-for-one. F3 notes a prior RSU grant (Feb 18, 2025) that vests in future installments.
• Timeliness: Filed Feb 19, 2026, appears timely (filed within the typical 2-business-day window).

Context This was primarily a vesting/settlement of equity awards with shares withheld to cover tax obligations (code F), not an open-market sale by the insider. Exercise/conversion (code M) entries reflect settlement of derivative awards into common stock. Tax-withholding dispositions are routine and do not necessarily indicate a change in the insider’s market view.